You searched for: "" but we corrected it to "*"

Did you mean to search for ""? Click here to show those results.

The results has been filter on Catalogues containing EphMRA/ESOMAR Seminar 1991: 1993 And Beyond.
ANA has found 14 results for you, in 175 ms.
Didn’t find what you were looking for? Try the Advanced Search!

Research papers

(Data + data) × intelligence= Information

This paper will serve to re-emphasise several of the points made by the previous speaker, as well as revisiting other aspects of data interpretation in the pharmaceutical industry. It examines several of the more important areas where data...

Catalogue: EphMRA/ESOMAR Seminar 1991: 1993 And Beyond
Author: Charles Galsworthy
June 15, 1991

Research papers

Search for the real market and real development: The treatment days analysis

1993 and beyond there will be an ongoing harmonisation process of prices, presentations, patent terms, etc. in the pharmaceutical market of the EC. Individual industry and government actions and re-actions in addition will change the market...

Catalogue: EphMRA/ESOMAR Seminar 1991: 1993 And Beyond
Author: Horst Gunter Schneider
June 15, 1991

Research papers

Facets of socio-economic research and the desirable involvement of market research

Socio-economic research is a comparably young discipline in the pharmaceutical world. While target groups, aims and the basic method (converting medical properties of a health care measure product into economic consequences) do not differ very much,...

Catalogue: EphMRA/ESOMAR Seminar 1991: 1993 And Beyond
Author: Karin Buechner
June 15, 1991

Research papers

International information management

The role of on-line databases has been consistently developing in the pharmaceutical industry over the last 15 years. It is my firm belief that this role will increase in importance and impact in the next decade. Researchers have a need for faster...

Catalogue: EphMRA/ESOMAR Seminar 1991: 1993 And Beyond
Author: Simon Fitall
June 15, 1991

Research papers

The role of marketing research in identifying the need for cost benefit analysis

The requirement for new prescription drugs to justify their introduction in economic as well as clinical terms is being sought not only at the central, governmental, level but also at the level of the individual hospital and physician practice, where...

Catalogue: EphMRA/ESOMAR Seminar 1991: 1993 And Beyond
Author: David Dawson
March 6, 1991